The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025Neuro-steroid Mediated Control of Sleep Co-morbidities in Parkinson's Disease
Study Rationale: Sleep disorders affect a large proportion of people with Parkinson’s disease (PD) and are often refractory to standard medications. Excessive daytime sleepiness (EDS), which is...
-
Research Grant, 2025Modeling Parkinson’s Disease in Pre-clinical Models and Models Via Overexpression of Irregular-type and Mutant Alpha-synuclein
Study Rationale: Parkinson's disease is a serious brain condition that causes problems with movement and other body functions. Scientists know that a protein called alpha-synuclein builds up in the...
-
Research Grant, 2025Investigating Aggregate-specific Alpha-synuclein Antibodies and Proximity Ligation Assay as Quantitative Biomarkers in Parkinson’s Disease
Study Rationale: Our new MJFR14-proximity ligation assay (PLA) technique has demonstrated an ability to detect disease-associated aggregates of alpha-synuclein in brain tissue previously considered...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers, 2025Dried Blood Spot PNPO Activity as a Biomarker for the Stratification of Parkinson's Disease
Study Rationale: Parkinson’s disease starts much earlier than the signs appear and people seek diagnosis. Scientists are therefore searching for changes that are relevant to the disease that could be...
-
Neuronal Synuclein Disease Endotypes 2024, 2025Expanding Biomarker Characterization in Deeply Phenotyped DLB, PD and PDD Cohorts
-
Research Grant, 2025Scamps: Endosomal Membrane Proteins that Control Alpha-synuclein Traffic
Study Rationale: Parkinson’s Disease progresses with the death of nerve cells in the brain. Some forms of the disease run in families due to mutations in important genes. One of these genes is called...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.